FDA Approved: KLAYESTA — Original Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved KLAYESTA, a nystatin topical powder, via an original ANDA from Epic Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Candidiasis

Drugs mentioned

• KLAYESTA (Nystatin topical powder)

Snippet

ORIG AP for KLAYESTA (NYSTATIN TOPICAL POWDER)